Clinical Research Directory
Browse clinical research sites, groups, and studies.
PEP-buddy in COPD: Effect on Dyspnea Severity and Mechanism of Action
Sponsor: University Medical Center Groningen
Summary
Chronic dyspnea is the most characteristic symptom of patients with Chronic Obstructive Pulmonary Disease (COPD), with intermittent increases during exercise and other events.Despite optimal standard therapy, episodic dyspnea is a common occurrence in COPD. Recently, the PEP buddy was developed which is an easy-to use, hands-free device that generates positive expiratory pressure (PEP). Although currently the available evidence is limited, it indicates that utilizing the PEP-buddy can result in enhancements in dyspnea during exertion, exertional desaturation and overall quality of life. More research is needed to evaluate the effectiveness of this device and the long term usability, as well as getting more insight in the mechanism of action. Therefore, the aim of our study is to explore the potential of this device for patients with COPD and episodic breathlessness.
Official title: A Portable Dyspnea Relief Device for Episodic Breathlessness in COPD (PEP-buddy): Effect on Dyspnea Severity and Mechanism of Action
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
INTERVENTIONAL
Enrollment
25
Start Date
2024-01-31
Completion Date
2025-12-31
Last Updated
2025-03-27
Healthy Volunteers
No
Conditions
Interventions
PEP-buddy
PEP-buddy
Locations (1)
UMCG
Groningen, Netherlands